@oneorange, I think you are right, the Pfizer and Moderna vaccine news has affected SCGM a little. However, do not be confused that SCGM's main product is actually food packaging. I think Datuk Seri and his team were wise and agile in capitalizing the opportunity during this pandemic, by adding mask manufacturing machines into their fleet. In short term, hopefully SCGM could export their premium quality masks to United States. Last I read, it was pending approval from FDA.
If you read the announcements previously made by the company, you will realize that the cost of purchasing those machines are not high. The cost of raw materials probably are. The new factory is also large enough to accommodate those new production line (masks) without compromising the existing food packaging production line. In my opinion, depends on the recovery from Covid-19 and margin for mask production, SCGM could easily get out from mask production and continue to focus on food packaging.
2017 I bought this counter and it is heading South till 2019...I sold my stakes in 2018, halfway but too late... Early 2020, I earn it back when it heading North. Moral of the story? Don't hold on when it is starting to heading North, this is just my personal advice. Chances are everywhere, don't hold on to something going down... if you understand technical, it really shows no sign of return. Funds are more important than profits.
The QR this time will soar high! Definitely, the 2021 business outlook will be good compared to other sectors! High resin cost can be offset by business growth!
United Arab Emirates Claims China’s Sinopharm Vaccine Is 100% Effective At Preventing Moderate And Severe Covid-19
TOPLINE The experimental vaccine developed by China National Pharmaceutical Group, also known as Sinopharm, is 86% effective at preventing Covid-19 infection and 100% effective at preventing severe and moderate disease, health officials from the United Arab Emirates announced Wednesday, although with scarce detail provided about the trial.
The UAE health ministry cited an interim analysis of a late-stage clinical trial involving 31,000 volunteers as the source of its information, though neither they nor Sinopharm provided any data from the trial to validate the claims such as how many participants were infected or how many actually received the vaccine.
The ministry said “no serious safety concerns” were observed, though, again, no information on side effects was provided.
The ministry said the announcement is a “significant vote of confidence by the UAE’s health authorities in the safety and efficacy of this vaccine.”
The ministry added that it had officially registered the vaccine at the request of the manufacturer, which it says could eventually lead to the shot’s widespread authorization.
Quite pity for SCGM. Thermofoaming as their main sector, mask just their newly side income, but all the so called 'investor' claimed SCGM as health sector. Profit wont drop due to rising of raw material price as it bears by the customers themselves. Profit margin might not be new high as its quite hard for a company to keep stay all time new high.
The main reason why the share price drop as there's no more "teachers and sifu" buy call on it. The market fund has moved to recovery stock etc consumer, airlines, banking.
Good time for value investor to come in.
Post a Comment
People who like this
New Topic
You should check in on some of those fields below.
Title
Category
Comment
Confirmation
Click Confirm to delete this Forum Thread and all the associated comments.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
tokohM
432 posts
Posted by tokohM > 2020-11-17 11:22 | Report Abuse
why tguan and scgm are in same industry but have different fate